Preliminary results from the first 10 patients have shown that there is significant variability between the proportions of blue and red in brain metastases from varying tumour histologies as well as intra patient variability.
Abstract
CCAs are obtained by subtracting T1-weighted MRI sequences at 5 and 60 minutes. This creates a colour-map representing how contrast is cleared in tissues over time. Generally, blue demonstrates rapid contrast-clearance suggesting active tumour whilst red represents delayed clearance indicating poor/damaged vasculature. This has been widely used post-SRS treatment to help differentiate between tumour progression and radionecrosis. Different tumours have varying radionsenstivities based on differences in their radiobiology including levels of oxygenation and vascularity. In this study we have used CCA imaging pre-SRS to determine if the vascularity and contrast handling capacity differs between different histologies offering a potential insight into whether this may influence radioresistance and SRS response.
24 patients with 124 metastases of varying histology had pre-SRS CCAs. Radiotherapy-planning-CT scans were fused with the planning-post-contrast-T1-MRI, with consultant clinical oncologist-approved contoured targets, and the CCA-images. Threshold analysis was performed to obtain proportions of red and blue within the enhancing areas of each tumour.
Preliminary results from the first 10 patients have shown that there is significant variability between the proportions of blue and red in brain metastases (p = 0.0294) from varying tumour histologies as well as intra patient variability. We are currently analysing the next 14 patients to increase the robustness of our findings.
The temporal diffusion ratio (TDR) is a model free technique which uses diffusion MRI data to create contrast between voxels with and without restricted diffusion, and has previously been used to inform on cell sizes (typically, larger TDR implies larger cell size). In this study, we hypothesise that TDR may be u...
Elise Gwyther, Sahar Iqbal, J. Powell et al.· Neuro-Oncology· 0 citations
MRI radiomics showed promising discrimination for local recurrence but limited discrimination for metastasis, and should be interpreted with caution given the small number of events in the test set and warrant external validation in larger cohorts.
Yusuf Baytar, Fırat Atak, G. Yazici et al.· European Journal of Ophthalm...· 0 citations
Double‑dose gadolinium contrast for stereotactic radiosurgery (SRS) planning MRI can increase detection of brain metastases, but its clinical benefit remains uncertain. One hypothesised advantage is reduced need for repeat SRS by treating small lesions earlier. We compared outcomes in patients planned with double...
Amir Ameen, H. Rozati, Rachel Lewis et al.· Neuro-Oncology· 0 citations
THINKERS-X improved lesion-specific longitudinal prediction, temporal accuracy, and probabilistic calibration beyond THINKERS-Lung while materially altering exploratory dose-scenario evaluation in a subset of metastases.
J. Reyes, Constantinos G. Hadjipanayis, A. Niranjan· Clinical and Experimental Me...· 0 citations